Lambert Skoog
Overview
Explore the profile of Lambert Skoog including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1885
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fohlin H, Nordenskjold A, Rosell J, Ferno M, Fornander T, Ryden L, et al.
Acta Oncol
. 2024 Jul;
63:535-541.
PMID: 38967128
Background: Hormone receptor positivity predicts benefit from endocrine therapy but the knowledge about the long-term survival of patients with different tumor receptor levels is limited. In this study, we describe...
2.
Johansson A, Dar H, J van t Veer L, Tobin N, Perez-Tenorio G, Nordenskjold A, et al.
J Clin Oncol
. 2022 Jul;
40(35):4071-4082.
PMID: 35862873
Purpose: To assess the long-term (20-year) endocrine therapy benefit in premenopausal patients with breast cancer. Methods: Secondary analysis of the Stockholm trial (STO-5, 1990-1997) randomly assigning 924 premenopausal patients to...
3.
Johansson A, Christakou A, Iftimi A, Eriksson M, Tapia J, Skoog L, et al.
JAMA Netw Open
. 2021 Jun;
4(6):e2114716.
PMID: 34170304
Importance: Benign breast diseases (BBDs) are common and associated with breast cancer risk, yet the etiology and risk of BBDs have not been extensively studied. Objective: To investigate the risk...
4.
Vu Hong T, Nguyen Ba D, Skoog L, Ta Thanh V, Tani E
Cancer Control
. 2019 Jul;
26(1):1073274819865279.
PMID: 31343899
Little is known about breast cancer in Vietnamese women. Previous studies have reported the frequencies of prognostic factors of breast cancer in this population. The aim of this study was...
5.
Foukakis T, Lovrot J, Matikas A, Zerdes I, Lorent J, Tobin N, et al.
Br J Cancer
. 2018 Jan;
118(4):480-488.
PMID: 29370583
Background: Transcriptomic profiles have shown promise as predictors of response to neoadjuvant chemotherapy in breast cancer (BC). This study aimed to explore their predictive value in the advanced BC (ABC)...
6.
Tani E, Fuentes-Martinez N, Skoog L
Acta Cytol
. 2017 Jul;
61(4-5):305-315.
PMID: 28693009
The article "Aspiration Biopsy of Mammary Tumors in Diagnosis and Research - A Critical Review of 2,200 Cases" by Zajicek et al. [Acta Cytol 1967;11:169-175] is composed of two separate...
7.
Nordenskjold A, Fohlin H, Fornander T, Lofdahl B, Skoog L, Stal O
Breast Cancer Res Treat
. 2016 Oct;
160(2):313-322.
PMID: 27722840
Purpose: The independent predictive information from progesterone receptor (PgR) positivity for breast cancer treated with tamoxifen has been questioned after an overview by the Early Breast Cancer Trialists' Collaborative Group...
8.
Kimbung S, Johansson I, Danielsson A, Veerla S, Egyhazi Brage S, Frostvik Stolt M, et al.
Clin Cancer Res
. 2015 Aug;
22(1):146-57.
PMID: 26276891
Purpose: The complete molecular basis of the organ-specificity of metastasis is elusive. This study aimed to provide an independent characterization of the transcriptional landscape of breast cancer metastases with the...
9.
Sjostrom M, Hartman L, Grabau D, Fornander T, Malmstrom P, Nordenskjold B, et al.
Breast Cancer Res Treat
. 2014 Apr;
145(1):61-71.
PMID: 24715381
G protein-coupled estrogen receptor (GPER), or GPR30, is a membrane receptor reported to mediate non-genomic estrogen responses. Tamoxifen is a partial agonist at GPER in vitro. Here, we investigated if...
10.
Thang V, Skoog L, Luu H, Van T, Tani E
Breast J
. 2014 Mar;
20(3):333-5.
PMID: 24673847
No abstract available.